Barcelona, a city celebrated for its cultural richness and artistic flair, has once again established its reputation as a leader in medical research and innovation. The recent 37th Annual Congress of the European Society of Intensive Care Medicine (ESICM) LIVES 2024, held from October 5-9 at the International Barcelona Convention Centre, attracted over 5,000 professionals from across the globe. The attendees included intensive care physicians, anesthetists, trainees, and allied health professionals, representing more than 100 countries.
Among the notable contributors at this year’s congress was BMC, which made a significant impact by showcasing its advancements in airway clearance technology. The organisation presented two key topics: “What is it?” and “The Clinical Application of Mechanical Airway Clearance Technology,” highlighting its innovative CoughSync clinical application.
During mechanical ventilation, patients often experience suppression of their natural cough reflex due to decreased respiratory muscle function. This suppression can lead to a dangerous accumulation of airway secretions, increasing the risk of respiratory resistance, inadequate ventilation, and severe complications such as respiratory failure. Therefore, timely and effective secretion removal is crucial in intensive care settings.
On October 8, BMC hosted a symposium titled “Intensive Care Airway Clearance Technology,” which summarised the latest innovations in the field. Leading experts in anaesthesia and intensive care were invited to speak, discussing the differences between traditional sputum clearance methods and the more advanced In Exsufflators Mechanical Insufflation-Exsufflation (IL-MIE) techniques. They highlighted the advantages of IL-MIE over conventional methods, emphasising its effectiveness in improving patient outcomes.
From October 7-9, BMC’s Booth 4.12 showcased its In-Exsufflators (CoughSync 100EU) devices. The booth provided a clear overview of how these devices work, as explained by the on-site sales manager. The CoughSync 100EU is designed to be compatible with both spontaneous and controlled ventilation modes, simulating a natural cough to effectively clear airway secretions without causing discomfort or disrupting hemodynamic stability.
With over 20 years of global operations in the field of respiratory health, BMC has cultivated a deep understanding of the needs of patients and healthcare providers. The company’s commitment to continuous innovation and refined solutions demonstrates its dedication to enhancing patient outcomes and improving the quality of care in intensive care settings.
As Barcelona continues to attract key players in medical research and innovation, events like the ESICM LIVES 2024 congress underscore the city’s role in shaping the future of healthcare. The collaboration and exchange of ideas among professionals at the congress pave the way for advancements that can ultimately lead to better patient care across the globe.